Fzata, Inc.

Private

MarylandHealthcare & Life Scienceshttps://www.fzata.com/

Last Round

Grant

Sep 24, 2024

Total Funding Raised

$25M

Company Overview

Fzata, Inc. is a biopharmaceutical company that develops oral live biotherapeutic medicines using its proprietary Bioengineered Probiotic Yeast Medicines (BioPYM™) platform to treat gastrointestinal and gut-brain axis disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

live biotherapeuticoral biologicsdrug delivery systemsynthetic biologygut microbiome therapypill-based medicinetherapeutic proteinsantibody engineeringgastrointestinal disordersneedle-free deliverybiotech platformLBPmicrobiome drugbioengineeringdrug co-development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Fzata, Inc. Comps

Public and private peers based on sector, stage, and business model.

Fzata, Inc. comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Fzata, Inc. Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Sep 24, 2024
Series A	Jan 26, 2023
Grant	Jan 15, 2018

View all Funding Rounds

Fzata, Inc. Investors

Notable investors and investment history

Fzata, Inc. investors
Investor	Rounds
NIH RADx	Grant
TEDCO	Seed
National Institute of Neurological Disorders and Stroke (NINDS)	Grant

View all Investors

Fzata, Inc. Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Fzata, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Fzata, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersMaryland

Employee Range11

Year Founded2015

Last FundingSep 24, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.